Immunotherapy combined with chemotherapy without locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: two case reports and a literature review

Immunotherapy combined with chemotherapy without locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: two case reports and a literature review

BackgroundThere is no consensus regarding the optimal regimen for de novo metastatic nasopharyngeal carcinoma (dmNPC). Locoregional intensity modulated radiotherapy (LRRT) following palliative chemotherapy (PCT) has been shown to prolong the overall survival (OS) and improve the progression-free sur...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yingna Gao, Xiaoqiong Shi, Jianqiao He, Hui Yao, Guoning Yu, Lin Zhao, Yi Ma, Hongliang Zheng, Minhui Zhu, Caiyun Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	immunotherapy chemotherapy de novo metastatic nasopharyngeal carcinoma (dmNPC) Epstein-Barr virus (EBV) locoregional radiotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1467355/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular diagnosis of nasopharyngeal carcinoma: Past and future
by: Cheng-Lung Hsu, et al.
Published: (2025-02-01)

Integrated Early CRP Kinetics and Plasma EBV DNA Clearance as Prognostic Biomarkers in De Novo Metastatic Nasopharyngeal Carcinoma Treated with First-Line Chemoimmunotherapy
by: Fang M, et al.
Published: (2025-05-01)

Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas
by: Ying Li, et al.
Published: (2025-08-01)

A nomogram integrating clinical stage and pre-EBV DNA to identify the cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Sunqin Cai, et al.
Published: (2025-06-01)

Genetic Characterization of the Immortalized Human Nasopharyngeal Carcinoma Cell Line NPC/HK1
by: Anna Makowska, et al.
Published: (2025-02-01)

Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
by: D. A. Miroshnichenko, et al.
Published: (2020-11-01)

Advancements in the epidemiology of nasopharyngeal carcinoma
by: DU Yun, et al.
Published: (2024-09-01)

EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma
by: Weiwei Zhang, et al.
Published: (2025-04-01)

Screening for nasopharyngeal carcinoma in high-incidence regions——Next steps
by: Allan Hildesheim
Published: (2024-09-01)

Re-searching nasopharyngeal carcinoma
by: Ingemar Ernberg, et al.
Published: (2024-09-01)

Cost-effectiveness analysis of sintilimab additional to chemoradiotherapy in high-risk locoregionally advanced nasopharyngeal carcinoma
by: Longjiang She, et al.
Published: (2025-07-01)

The burden and outcome of nasopharyngeal carcinoma in Sweden
by: Evelina Gille, et al.
Published: (2025-07-01)

The abnormally high expression of RAB11A promotes the invasion of nasopharyngeal carcinoma
by: ZHOU Lu, et al.
Published: (2025-02-01)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
by: Han Zhou, et al.
Published: (2020-04-01)

Long-term results of locoregionally advanced nasopharyngeal carcinoma treated with cisplatin and 5-fluorouracil induction chemotherapy with or without docetaxel in young and middle aged adults
by: Yuming Zheng, et al.
Published: (2025-03-01)

Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens
by: Xue-Qi Li, et al.
Published: (2025-07-01)

Challenges in diagnosing nasopharyngeal tumors
by: Alexandru Aristide Alexe, et al.
Published: (2024-10-01)

Epidemiology and treatment outcome of nasopharyngeal carcinoma in a low-incidence population – a DAHANCA analysis in Denmark 2000–2018
by: Erik Schiess, et al.
Published: (2024-11-01)

Exploring the interplay between EBV and autophagy-related gene expression patterns in nasopharyngeal carcinoma
by: Abdullah E. Alanazi, et al.
Published: (2025-06-01)

First Indonesian Nasopharyngeal Cancer Whole Epigenome Sequencing Identify Tumour Suppressor CpG Methylation
by: Handoko, et al.
Published: (2025-01-01)

Comparison between ELISA and PCR for Detection of Epstein - Barr virus in children with acute cervical lymphadenitis
by: Nazim Khan, et al.
Published: (2024-11-01)

A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
by: Anna Spreafico, et al.
Published: (2025-01-01)

Epstein-Barr virus-associated autoimmune hemolytic anemia: a clinical report and review of literature
by: Salvatore Accomando, et al.
Published: (2025-04-01)

Epstein-Barr virus type 2 infection is associated with higher viral loads in pediatric tonsils from western Kenya
by: Emmily Koech, et al.
Published: (2025-08-01)

Clinical features and laboratory findings in children hospitalized with acute Epstein-Barr virus infection: a crosssectional study in a tertiary care hospital
by: İlknur Çağlar, et al.
Published: (2019-06-01)

The clinical and laboratory characteristics of infectious mononucleosis caused by the Epstein-Barr virus type 1 in hospitalized children
by: M. I. Popkova, et al.
Published: (2023-04-01)

A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness
by: KaMaría José Lista, et al.
Published: (2017-08-01)

Early diagnosis and personalized comprehensive treatment of nasopharyngeal carcinoma based on Epstein-Barr virus-specific markers
by: CHEN Jie, et al.
Published: (2024-09-01)

CRISPR/Cas13-Mediated Inhibition of EBNA1 for Suppression of Epstein–Barr Virus Transcripts and DNA Load in Nasopharyngeal Carcinoma Cells
by: Lin Lin, et al.
Published: (2025-06-01)

A Liposome-Based Nanoparticle Vaccine Induces Effective Immunity Against EBV Infection
by: Ping Li, et al.
Published: (2025-03-01)

Drought-compounded stress and immune function in Kenyan pastoralist boys and girls occupying contrasting climate zones
by: Bilinda Straight, et al.
Published: (2025-12-01)

Effect of locoregional surgery in primary tumors on overall survival in patients with de novo stage IV breast cancer: a systematic review and meta-analysis
by: Yanbo Sun, et al.
Published: (2025-05-01)

A Nomogram Based on Tumor Response to Induction Chemotherapy and Plasma Epstein–Barr Virus DNA Level after Induction Chemotherapy to Explore Individualized Treatment of Patients with Locally Advanced Nasopharyngeal Carcinoma
by: Liu F, et al.
Published: (2025-03-01)

Patterns of failure and prognosis in nasopharyngeal carcinoma according to Epstein-Barr virus DNA status
by: Lin-Feng Guo, et al.
Published: (2025-02-01)

Leveraging Artificial Intelligence and Radiomics for Improved Nasopharyngeal Carcinoma Prognostication
by: Nicholas Brian Shannon, et al.
Published: (2025-03-01)

Anti-Epstein–Barr Virus Activities of Flavones and Flavonols with Effects on Virus-Related Cancers
by: Sherif T. S. Hassan
Published: (2025-02-01)

Computational biology assisted exploration of phytochemicals derived natural inhibitors to block BZLF1 gene activation of Epstein–Bar virus in host
by: Muhammad Naveed, et al.
Published: (2024-12-01)

The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study
by: Mengting Xu, et al.
Published: (2025-02-01)

Epstein-Barr virus (EBV) infection of endothelial cells via endocytosis is associated with a poor prognosis in nasopharyngeal carcinoma
by: Xu-lin Chen, et al.
Published: (2025-08-01)

Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy
by: Mengting Shi, et al.
Published: (2023-12-01)